Hikma Pharmaceuticals PLC (LON:HIK)
London · Delayed Price · Currency is GBP · Price in GBX 1,411.97
-17.53 (-1.23%)
May 7, 2026, 2:45 PM GMT
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 3.07 billion as of May 7, 2026. Its market cap has decreased by -26.82% in one year.
Market Cap
3.07B
Enterprise Value
4.09B
Revenue
2.49B
Ranking
n/a
PE Ratio
10.63
Stock Price
1,411.97
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 3.07B, an increase of 553.98%. That is a compound annual growth rate of 9.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 3.07B | -10.52% |
| Dec 31, 2025 | 3.43B | -22.33% |
| Dec 31, 2024 | 4.42B | 11.74% |
| Dec 29, 2023 | 3.96B | 15.72% |
| Dec 30, 2022 | 3.42B | -33.45% |
| Dec 31, 2021 | 5.14B | -11.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haleon | 30.56B |
| HUTCHMED (China) | 1.68B |
| Allergy Therapeutics | 649.08M |
| Shield Therapeutics | 84.41M |
| Venture Life Group | 68.83M |
| ECO Animal Health Group | 63.36M |
| Provexis | 23.93M |
| Chill Brands Group | 2.09M |